Ian T Meredith Boston Scientific Corp (BSX) insider trading activity

BSX Quotes by TradingView

Ian T Meredith is EVP Global Chief Med Officer of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 28,082 shares of BSX, which is worth approximately $2.55 Million. The most recent transaction as insider was on Feb 10, 2021, when has been sold 4,318 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
0% 3M change
0% 12M change
Total Value Held $2.55 Million

Ian T Meredith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2021
BUY
Grant, award, or other acquisition
-
4,318 Added 12.27%
30,874 Common Stock
Feb 01 2021
SELL
Payment of exercise price or tax liability
$33,038 $35.95 p/Share
919 Reduced 3.34%
26,556 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
-
3,130 Added 10.23%
27,475 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$76,466 $35.95 p/Share
2,127 Reduced 8.03%
24,345 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
6,527 Added 19.78%
26,472 Common Stock
ITM

Ian T Meredith

EVP Global Chief Med Officer
Marlborough, MA

Track Institutional and Insider Activities on BSX

Follow BOSTON SCIENTIFIC CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

News

Receive news related to BOSTON SCIENTIFIC CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BSX